Immunocompromised children hospitalized with influenza received intensive care less frequently but had a longer hospitalization duration than nonimmunocompromised children, a new study found. Researchers analyzed data from the 2011-2012 through 2014-2015 influenza seasons and compared clinical features and outcomes between the immunocompromised and nonimmunocompromised children aged <18 years hospitalized with laboratory-confirmed community-acquired influenza. They found:
- Among 5,262 hospitalized children, 242 (4.6%) were immunocompromised; receipt of nonsteroidal immunosuppressive therapy, cancer, and solid organ transplantation were most common.
- Immunocompromised children were older, more likely to have comorbidity, and more likely to have received an influenza vaccination and early antiviral treatment.
- In multivariable analyses, immunocompromised children were less likely to receive intensive care and had a slightly longer duration of hospitalization.
- Death was uncommon in both groups.
Collins JP, Campbell AP, Openo K, et al. Clinical features and outcomes of immunocompromised children hospitalized with laboratory-confirmed influenza in the United States, 2011–2015. [Published online ahead of print October 25, 2018]. J Pediatric Infect Dis Soc. doi:10.1093/jpids/piy101.
Must Reads in Influenza
Influenza Vaccination Effectiveness in the US, Clin Infect Dis; ePub 2019 Feb 2; Rolfes, et al
Influenza Associated Outcomes in Pregnancy, J Infect Dis; ePub 2019 Jan 23; Prasad, et al
Influenza Effects in Patients with Heart Failure, JACC Heart Fail; ePub 2019 Jan 2; Panhwar, et al